Back to catalogue
№ 247 27 filings · 2021-10-18 → 2026-06-25

MIND GYM PLC

MIND
Industrial Goods and Services Share price 7.25p Market cap £7.28m Overall fit 220 /1000

Poor fit: negligible-to-negative AI exposure (AI actually cannibalising L&D demand), sub-scale operating leverage in absolute terms, weak downside protection (going concern uncertainty). Upside is real but driven by M&A optionality rather than the AI thesis the investor wants exposure to.

Fair value range 10p–18p Mid case · £14m
Absolute upside +92.4% vs current market cap
Conviction 2/5 confidence in undervalued call
Supports the call
  • Confirmed strategic review provides M&A anchor
  • Clean, detailed disclosure of transformation KPIs and cost base
  • Demonstrated H2 FY26 operating leverage from cost cuts
Limits the call
  • Material uncertainty over going concern flagged by auditor
  • Three consecutive years of missed initial guidance make forward numbers unreliable
Methodology

Blended M&A takeout multiple and recovery-scenario EBITDA multiple

In one line · bull case

Distressed micro-cap behavioural-science provider with recurring-revenue transformation underway and a confirmed strategic review providing near-dated M&A optionality at a fraction of historic value.

In one line · biggest risk

Going concern uncertainty combined with continued revenue decline could force a heavily dilutive rescue or worse if the strategic review fails to yield an offer.

Drivers
AI beneficiary 15 /100
AI is a competitive threat — management cites AI-enabled HR tech as reason US clients are pausing spend; own Lio AI coach is marginal.
Operating leverage 60 /100
87% gross margin and largely fixed cost base give strong incremental margins, but sub-scale (£30m revenue) limits absolute pound impact.
Earnings vs expectations 20 /100
Multiple guidance cuts in FY24 and FY25; delivered against successively lowered bars, not initial expectations.
Growth momentum 15 /100
Three consecutive years of revenue decline (–14%, –14%, –23%); Q1 FY27 slow start.
Moat 30 /100
Some proprietary IP (High Performance Behaviour Model, 10X psychometric) and blue-chip client relationships, but market is highly fragmented and execution-dependent.
Earnings quality 30 /100
Three consecutive years of digital-asset impairments totalling £14m; wide gap between statutory losses and 'adjusted' figures.
Management quality 35 /100
Founder-controlled; Chair transitioned back to Executive Chair; new CEO delivering cost cuts but revenue keeps falling; interim CFO covering maternity.
Cyclicality 60 /100
HR/L&D spend is discretionary and cyclical; DEI cutbacks and geopolitical uncertainty have amplified this.
Leverage 40 /100
Small overdraft draw of £0.8m and net debt of £0.3m; net liabilities on balance sheet; overdraft facility halved to £2m on renewal.
Value-trap signals · 6
  • Three consecutive years of double-digit revenue decline
  • Three consecutive years of major digital-asset impairments (£14m cumulative)
  • Material uncertainty over going concern in FY26 audit report
  • Overdraft facility halved from £4m to £2m on renewal
  • Founder-controlled with limited independent oversight
  • Repeated guidance cuts followed by delivery against lowered bars

MIND GYM PLC (MIND) — Investment research note

Executive summary

MindGym is a UK AIM-listed behavioural science / L&D services provider selling leadership, culture and productivity programmes to blue-chip corporates (60%+ of FTSE 100 & S&P 100 as historic clients), currently mid-way through a three-year transformation from episodic training to recurring licensing/membership. The operating trajectory has been sharply negative — revenue has fallen from £55.0m (FY23) → £44.9m (FY24) → £38.6m (FY25) → £29.9m (FY26), with statutory pre-tax losses of £12.1m, £6.2m and £5.2m respectively, and repeated digital-asset impairments (£6.6m FY24, £4.4m FY25, £3.0m FY26). The single most important valuation point today is the ongoing private strategic review confirmed on 27 January 2026 that "may … result in an offer for the Company" — this sets an implicit floor/ceiling to fair value that overwhelms conventional multiples on a business the auditors flag with a material uncertainty over going concern.

Fair value estimate

  • Fair value range: 10p – 18p per share → implied market cap £10m – £18m.
  • Methodology: sum of two triangulated approaches:
    1. Trade sale / strategic-review takeout: 0.4x–0.6x LTM revenue (£29.9m) = £12–18m, in line with distressed / sub-scale UK B2B services deals; blue-chip client roster, proprietary IP (High Performance Behaviour Model, 10X psychometric), £19.4m unrecognised UK tax losses (£4.9m deferred tax asset) and 87% gross margin support the upper end.
    2. Standalone recovery: if FY27 delivers "modest growth" and £2m adj EBITDA at scale (management's medium-term aspiration is 15%+ margins on higher revenue), 5–7x = £10–14m enterprise value; net debt ~£0.3m makes EV≈equity. Discounted for going-concern risk lands at the lower end.
  • Mid-point ~£14m ≈ 14p per share vs current 8.5pabsolute upside ~65% to mid.
  • However the going-concern qualification, £2m residual overdraft only, and continued Q1 FY27 softness mean a downside case of 3–5p (equity wipeout / heavily dilutive rescue) is real if the strategic review fails.

Sector context

  • Sector: Industrials → Industrial Goods & Services. In practice this is a professional services / L&D micro-cap, mis-classified within Industrials.
  • Quality, growth and leverage profile is materially below typical Industrial Goods peers: sub-scale, loss-making, structurally declining, near-zero net cash, material uncertainty over going concern.
  • Listed comparables are scarce: Learning Technologies Group (LTG) (recently taken private), Instructure (INST) and Pluralsight on the digital side; Kin & Carta, Alpha FMC on the specialist consulting side. All materially larger and better capitalised.

Investment thesis (3 bullets)

  • Strategic review is a real, near-dated catalyst. Board is in confirmed discussions with third parties "that may … result in an offer" 2026-06-25 final results & 2026-01-27 announcement. Micro-cap trading at £8.5m with £19.4m of unrecognised UK tax losses, proprietary IP and blue-chip client relationships is a plausible tuck-in for a larger HR-tech / consulting acquirer.
  • Recurring revenue mix has genuinely turned. MindGym Memberships grew from 11 → 62 customers YoY; licensing/membership went from 9% → 17% of revenue (26% in Q4 FY26), deferred income +31%, cash conversion improving 2026-06-25 final results. If sustained, transforms the earnings quality and multiple.
  • Cost base has been reset; H2 FY26 returned to adjusted EBITDA profitability despite the £6m headwind from the concluded energy framework. A further £2m annualised cost programme is underway for FY27, and gross margin is 87.2% — meaning any modest revenue reacceleration would drop disproportionately to profit 2026-06-25 final results.

Key risks (3 bullets)

  • Material uncertainty over going concern. FY26 auditor drew attention to going-concern material uncertainty; overdraft facility was reduced from £4m to £2m in April 2026; net debt £0.3m and net liabilities £1.6m at 31 March 2026 2026-06-25 final results, Note 2.
  • Structural revenue decline, not a one-off. Revenue has fallen for three consecutive years; Q1 FY27 has "begun more slowly than we would have liked" and the £3.0m FY26 diagnostic impairment is the third consecutive year of impairing internally-built platforms — evidence that MindGym cannot execute proprietary tech at scale and is now dependent on partners (Administrate, EvolveAssess, Thought Industries) 2026-06-25 & 2025-06-12 final results.
  • AI is a competitive threat, not a tailwind, in the US. Management explicitly acknowledges that "AI-enabled HR technology is currently the focus of corporate buyers" causing customer caution — the very AI wave the investor wants to ride is destroying MindGym's US pipeline 2025-12-04 half-year results, Strategic Update.

Operating leverage

On paper MindGym has attractive operating leverage: gross margin is 87.2% and rising, cost base is largely fixed people/overhead, and FY26 saw adjusted admin expenses fall 19% while gross margin expanded. In the second half of FY26 revenue grew ~20% H2/H1 and adjusted EBITDA swung from a £1.0m H1 loss to a £1.6m H2 profit — a demonstrated ~£2.6m EBITDA swing on ~£3m of incremental revenue, i.e. very high incremental margins in the ~85% zone once the fixed cost base is covered. Applied forward: if FY27 revenue reaches £33-35m (management guides "modest growth"), incremental £3-5m of gross profit against a broadly flat post-cut cost base would deliver £2-3m of adjusted EBITDA — roughly quadruple current levels. That said, the business is sub-scale (£29.9m revenue, 172 employees), so operating leverage is real in ratio terms but tiny in absolute pound terms; it will not compound into anything meaningful without a return to £45–50m+ revenue, which requires solving the demand problem the transformation is meant to fix 2026-06-25 final results financial review.

Value-trap signals

  • Three consecutive years of double-digit revenue decline (FY24 –14%, FY25 –14%, FY26 –23%).
  • Three consecutive years of major digital-asset impairments (£6.6m + £4.4m + £3.0m = £14m) indicating capex on internal builds has been repeatedly written off.
  • Material uncertainty over going concern; overdraft facility halved on renewal.
  • Repeated guidance cuts across FY24 and FY25.
  • Founder-controlled (O. Black & J. Cash jointly control the company); no independent Chair; Chair transitioned back to Executive Chair role.
  • CFO on maternity leave with interim replacement.
  • Dividend suspended since IPO era; no capital return.

Earnings vs. expectations

  • FY23: In-line/beat — hit market expectations, +13% revenue, £3.0m PBT profit.
  • FY24: Miss — pre-guidance was for growth; delivered –14% revenue and £12.1m statutory loss (£8.9m exceptionals). October 2023 half-year trading update guided down.
  • FY25: Guided down further in March 2025; delivered in line with revised expectations at £38.6m revenue, £1.9m adj EBITDA (vs. loss guidance from a year earlier — restructuring drove the improvement).
  • FY26: In line with revised expectations after further guidance reduction in Dec 2025. Delivered £29.9m revenue, £0.6m adj EBITDA (against £1.9m FY25).
  • Pattern: repeated misses vs original expectations followed by delivery against successively lowered internal bars. The Board has recalibrated aggressively rather than committed to fresh targets.

Conviction

Conviction: 2 (low).

Anchoring the estimate: (1) the strategic-review announcement provides a real M&A anchor for value, (2) FY26 disclosure is clean and detailed on transformation KPIs (memberships, recurring mix, cost cuts), (3) high gross margin and demonstrated H2 operating leverage inform the recovery scenario.

Limiting conviction: (1) auditors flagged material uncertainty over going concern — a discrete binary event I cannot price precisely; (2) outcome of the strategic review is unknowable and will overwhelm fundamental value; (3) three consecutive years of missed initial guidance make forward numbers unreliable.

Driver commentary (summary)

  • AI beneficiary: Very low — AI is a substitute for corporate training content; management explicitly cites AI-enabled HR tech as a headwind reducing US demand.
  • Operating leverage: Moderate-to-good in ratio terms (87% GM, largely fixed base), but sub-scale absolute size limits how meaningful any upside surprise could be.
  • Downside protection: Weak. Micro-cap, going concern material uncertainty, minimal cash cushion.

Overall fit with the strategy is poor — this is a distressed micro-cap turnaround / event-driven play, not an AI-receiver with valuation discipline and downside protection. The upside from here is largely M&A optionality rather than operational compounding on AI demand.

Filings consulted · 29

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-06-25Final Results For The Year Ended 31 March 20262026-06-25_9635392_final-results-for-the-year-ended-31-march-2026.md1.00
  2. 2026-04-02Year End Trading Update2026-04-02_9505515_year-end-trading-update.md0.85
  3. 2025-12-04Half Year Results2025-12-04_9274608_half-year-results.md0.77
  4. 2025-10-21Half Year Trading Update2025-10-21_9183055_half-year-trading-update.md0.77
  5. 2025-09-17Result OF Agm2025-09-17_9114467_result-of-agm.md0.26
  6. 2025-06-12Final Results For The Year Ended 31 March 20252025-06-12_8925289_final-results-for-the-year-ended-31-march-2025.md0.65
  7. 2025-03-31Full Year Trading Update And Notice OF Results2025-03-31_8804127_full-year-trading-update-and-notice-of-results.md0.55
  8. 2024-12-03Half Year Results2024-12-03_8585967_half-year-results.md0.58
  9. 2024-10-22Half Year Trading Update Amp Notice OF Results2024-10-22_8499955_half-year-trading-update-amp-notice-of-results.md0.58
  10. 2024-06-24Notice OF Agm2024-06-24_8275373_notice-of-agm.md0.14
  11. 2024-06-17Final Results For The Year Ended 31 March 20242024-06-17_8261725_final-results-for-the-year-ended-31-march-2024.md0.45
  12. 2024-04-22Full Year Trading Update2024-04-22_8148200_full-year-trading-update.md0.38
  13. 2023-12-01Half Year Results2023-12-01_7915068_half-year-results.md0.41
  14. 2023-10-09Half Year Trading Update Amp Notice OF Results2023-10-09_7803713_half-year-trading-update-amp-notice-of-results.md0.41
  15. 2023-06-28Notice OF Agm2023-06-28_7600378_notice-of-agm.md0.07
  16. 2023-06-15Notice OF Investor Presentation2023-06-15_7575865_notice-of-investor-presentation.md0.17
  17. 2023-06-13Full Year Results2023-06-13_7571373_full-year-results.md0.25
  18. 2023-04-24Full Year Trading Update2023-04-24_1532_full-year-trading-update.md0.21
  19. 2023-04-24Full Year Trading Update2023-04-24_7494880_full-year-trading-update.md0.21
  20. 2022-12-13Investor Presentation2022-12-13_7408095_investor-presentation.md0.17
  21. 2022-12-02Half Year Results2022-12-02_7267285_half-year-results.md0.23
  22. 2022-10-18Half Year Trading Update2022-10-18_7351353_half-year-trading-update.md0.23
  23. 2022-07-14Result OF Agm2022-07-14_7032121_result-of-agm.md0.07
  24. 2022-06-21Publication OF Annual Report And Notice OF Agm2022-06-21_7022509_publication-of-annual-report-and-notice-of-agm.md0.24
  25. 2022-06-10Full Year Results2022-06-10_6876163_full-year-results.md0.25
  26. 2022-05-27Notice OF Full Year Results2022-05-27_7030174_notice-of-full-year-results.md0.25
  27. 2022-04-25Full Year Trading Update2022-04-25_7039583_full-year-trading-update.md0.21
  28. 2021-12-03Half Year Results2021-12-03_6680580_half-year-results.md0.23
  29. 2021-10-18Half Year Trading Update2021-10-18_6814874_half-year-trading-update.md0.23

This research note was authored by a large language model after reading 27 regulatory filings published between 2021-10-18 and 2026-06-25. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.